Nippon India Pharma Fund vs UTI Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High Risk | Very High Risk |
Asset Size (Cr) | ₹8161 Cr | ₹1150 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 30 Jul 2005 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 28% |
Expense Ratio | 1.82 | 2.22 |
Manager | Sailesh Raj Bhan | Kamal Gada |
ISIN Code | INF204K01968 | INF789F01695 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Month | -6% | -7.16% |
6 Month | -8.47% | -5.65% |
1 Year | 6.77% | 13.85% |
3 Year | 18.71% | 19.5% |
5 Year | 22.93% | 22.94% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
6 Month | - | - |
1 Year | -1.87% | 3.71% |
3 Year | 21.17% | 23.91% |
5 Year | 19.06% | 19.77% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Year | 18.19% | 11.43% |
3 Year | 20.5% | 16.02% |
5 Year | 20.36% | 14.18% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Standard Deviation | 15.185% | 15.78% |
Sharp | 0.81% | 0.837% |
Beta | 0.931% | 0.968% |
Alpha | -0.33% | 0.08% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Name | Sailesh Raj Bhan | Kamal Gada |
Total AUM | ₹96086 Cr | ₹870 Cr |
Fund Manage | 5 | 1 |
Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 4.4 | 1.53 |
Large Cap | 45.96 | 32.81 |
Mid Cap | 27.12 | 26.59 |
Small Cap | 22.52 | 39.04 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 4.4 | 1.53 |
Pharmaceuticals & Biotechnology | 75.86 | 75.33 |
Healthcare Services | 17.38 | 21.22 |
Retailing | 2.36 | - |
Healthcare Equipment & Supplies | - | 0.85 |
Insurance | - | 1.04 |
Top Comparisons
Aditya Birla Sun Life Equity Hybrid 95 Fund - Regular Plan-Growth
3Y Returns8.47%
Edelweiss Aggressive Hybrid Fund - Regular Plan - Growth Option
3Y Returns14.97%
Nippon India Floating Rate Fund - Growth Plan-Growth Option
3Y Returns6.52%
Tata Floating Rate Fund-Regular Plan-Growth
3Y Returns6.49%
Bandhan Financial Services Fund - Regular (G)
3Y Returns0%
DSP Banking & Financial Services Fund - Reg (G)
3Y Returns0%
Bajaj Finserv Overnight Fund Regular - Growth
3Y Returns0%
Bandhan Overnight Fund Regular - Growth
3Y Returns6.08%